NCT01316848View on ClinicalTrials.gov

A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Food Effect of Tivozanib in Health Subjects
Interventions
DRUG

tivozanib

tivozanib 1.5 mg capsule, 2 discrete single doses separated by 6-weeks

Trial Locations (1)

Unknown

Covance Clinical Research Unit, Inc., Dallas

Sponsors
All Listed Sponsors
lead

AVEO Pharmaceuticals, Inc.

INDUSTRY

NCT01316848 - A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy Subjects | Biotech Hunter | Biotech Hunter